ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
University Of Iowa To Begin Using LUMA(R) Cervical Pre Cancer Imaging Device
SpectraScience, Inc. (OTC
Bulletin Board: SCIE), a San Diego-based medical devices company,
announced that it has placed its LUMA Cervical Imaging System to detect
pre-cancers at the University of Iowa in Iowa City, Iowa under the
direction of Dr. Colleen Kennedy.
Dr. Kennedy stated, "We are indebted to the John and Mary Pappajohn
Cancer Center Fund for their generous donation allowing us to implement the
LUMA system at the University of Iowa. We look forward to benefiting from
the enhanced productivity that it provides and, more importantly, for the
ability to provide better patient care and outcomes. We are the only
medical center currently in the mid-west providing this state-of-the art
technology."
The LUMA Cervical Imaging System was developed to significantly improve
the detection of high-grade precancerous cervical abnormalities that have
the potential to become invasive cancer. Based on data from the National
ALTS study, it is estimated that precancerous disease goes undiagnosed in
about 200,000 women each year.
The LUMA System provides a safe and effective method, that when used as
an adjunct to colposcopy, has been demonstrated to uncover at least 26%
more high-grade precancerous disease than colposcopy alone. The latter is
the current gold standard following an abnormal Pap test.
SpectraScience CEO Jim Hitchin commented, "We are pleased to have
placed our LUMA System at the prestigious University of Iowa facility and
believe that it is a strong validation of our technology. We are committed
to developing and bringing more effective cancer screening technologies to
the market with the result of better and earlier diagnosis."
Management estimates that the there are more than 2 million procedures
performed annually at more than 1,600 sites throughout the U.S. The
University of Iowa performs approximately 1,300 procedures annually.
SpectraScience has filed for 60 patents worldwide on its WavSTAT(R)
Optical Biopsy System and LUMA Cervical Cancer Imaging System that are used
to diagnose tissue to determine within seconds if it is normal,
pre-cancerous, or cancerous. The WavSTAT and LUMA systems are currently
approved by the FDA for detecting pre-cancer and cancer in the colon and
cervix, and an evaluation for detection of pre-cancers in the throat
("Barrett's esophagus") is being tested.
This news release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. These
forward-looking statements involve risks and uncertainties that may cause
SpectraScience's actual results to differ materially from results discussed
in forward-looking statements. Readers are urged to carefully review and
consider the various disclosures made by SpectraScience in this news
release, its most recent Form 10-K and in SpectraScience's other reports
filed with the Securities and Exchange Commission ("SEC") that attempt to
advise interested parties of the risks and factors that may affect
SpectraScience's business. These forward- looking statements are qualified
in their entirety by the cautions and risk factors filed by SpectraScience
in its annual report on Form 10-K and other documents.
About University of Iowa Healthcare
University of Iowa Health Care is a fully integrated academic medical
center, uniting the UI Roy J. and Lucille A. Carver College of Medicine,
University of Iowa Hospitals and Clinics, and UI Physicians, the largest
multi-specialty group practice in Iowa. As the state's premier academic
medical center, UI Health Care provides high quality, patient-centered
care, conducts groundbreaking biomedical research, and educates the
scientists and health care providers of the future.
About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that
designs, develops, manufactures and markets spectrophotometry systems
capable of determining whether tissue is normal, pre-cancerous or cancerous
without physically removing tissue from the body. The WavSTAT Optical
Biopsy System uses light to optically scan tissue and provide the physician
with an immediate analysis. With FDA approval for sale in the U.S. and the
CE Mark for the European Union, the WavSTAT System is the first
commercially available product that incorporates this innovative technology
for clinical use. The Company's LUMA imaging technology has received FDA
approval for an optical non-invasive system that is proven to more
effectively detect cervical cancer precursors than conventional methods
available in the market.
SpectraScience, Inc.
http://www.spectrascience.com
Universitatea din Iowa a începe sã folosiþi Luma (R) Cancer de col uterin Pre Imagine Aparat - University Of Iowa To Begin Using LUMA(R) Cervical Pre Cancer Imaging Device - articole medicale engleza - startsanatate